Alexander Kristen
SEC CIK 1878867 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS, INC. | VP, Fin, Accounting | 94.2K | — | — | 8 | 2022-02-28 | 2025-02-28 |
Most active insiders at LXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Artal Group S.A. | Dir, 10% | $2.00M | — |
| 2 | DEBBANE RAYMOND | Dir | $723.0K | — |
| 3 | Martens Rachel Yap | SVP, Partnerships, Corp Strat | — | — |
| 4 | Gopinathan Suma | SVP, Discovery | — | — |
| 5 | Artal Participations S.a r.l. | Dir, 10% | — | — |
| 6 | Cheung Ivan | Dir | — | — |
| 7 | Exton Michael | CEO, Dir | — | — |
| 8 | Sullivan Diane E. | Dir | — | — |
| 9 | McDermott Wendy | SVP, Human Resources | — | — |
| 10 | Granowitz Craig B | SVP, Chief Medical Off | — | — |
Alexander Kristen made no open-market trades at LXRX in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-03 | 2025-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | Alexander Kristen | VP, Fin, Accounting | M - OptEx | — | +46.4K | 94.2K | +97% | — |
| D | 2025-03-03 | 2025-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | Alexander Kristen | VP, Fin, Accounting | F - Tax | $0.67 | -17.9K | 76.4K | -19% | -$12.0K |
| D | 2024-02-29 | 2024-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | Alexander Kristen | VP, Fin, Accounting | F - Tax | $2.62 | -11.8K | 47.8K | -20% | -$30.9K |
| DM | 2024-02-29 | 2024-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | Alexander Kristen | VP, Fin, Accounting | M - OptEx | — | +29.2K | 59.6K | +96% | — |
| DM | 2023-03-01 | 2023-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | Alexander Kristen | VP, Fin, Accounting | M - OptEx | — | +18.7K | 35.7K | +110% | — |
| D | 2023-03-01 | 2023-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | Alexander Kristen | VP, Fin, Accounting | F - Tax | $2.17 | -5,330 | 30.4K | -15% | -$11.6K |
| DM | 2022-02-28 | 2022-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | Alexander Kristen | VP, Fin, Accounting | M - OptEx | — | +11.3K | 20.3K | +126% | — |
| D | 2022-02-28 | 2022-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | Alexander Kristen | VP, Fin, Accounting | F - Tax | $2.85 | -3,337 | 17.0K | -16% | -$9,510 |
Purchase Sale Sale after option exercise All abbreviations